BloombergLean L·
Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
Read at Bloomberg →
Markets · 1 sources covering this
Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.
Coverage spectrum
1 L · 0 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/578a8e0f3c833471371f6463ba4a020cf5b89a99" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials"></iframe>
